| Three-Tesla magnetic resonance–guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound … CMA Hoeks, MG Schouten, JGR Bomers, SP Hoogendoorn, ... European urology 62 (5), 902-909, 2012 | 326 | 2012 |
| EAU-EANM-ESTRO-ESUR-SIOG prostate cancer guideline panel consensus statements for deferred treatment with curative intent for localised prostate cancer from an international … TBL Lam, S MacLennan, PPM Willemse, MD Mason, K Plass, R Shepherd, ... European urology 76 (6), 790-813, 2019 | 211 | 2019 |
| Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome HA Bogers, JPM Sedelaar, HP Beerlage, JJ de la Rosette, FMJ Debruyne, ... Urology 54 (1), 97-104, 1999 | 183 | 1999 |
| Results of targeted biopsy in men with magnetic resonance imaging lesions classified equivocal, likely or highly likely to be clinically significant prostate cancer W Venderink, A van Luijtelaar, JGR Bomers, M van der Leest, ... European urology 73 (3), 353-360, 2018 | 151 | 2018 |
| Steroidogenic enzymes and stem cell markers are upregulated during androgen deprivation in prostate cancer MJ Pfeiffer, FP Smit, JPM Sedelaar, JA Schalken Molecular medicine 17, 657-664, 2011 | 149 | 2011 |
| Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer JP Sedelaar, GJLH van Leenders, CA Hulsbergen-van de Kaa, ... European urology 40 (3), 285-293, 2001 | 132 | 2001 |
| Tissue culture media supplemented with 10% fetal calf serum contains a castrate level of testosterone JPM Sedelaar, JT Isaacs The Prostate 69 (16), 1724-1729, 2009 | 112 | 2009 |
| Three‐dimensional contrast‐enhanced power Doppler ultrasonography and conventional examination methods: the value of diagnostic predictors of prostate cancer D Unal, JPM Sedelaar, RG Aarnink, G Van Leenders, H Wijkstra, ... BJU international 86 (1), 58-64, 2000 | 102 | 2000 |
| Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma RJ Eckersley, JPM Sedelaar, MJK Blomley, H Wijkstra, NM DeSouza, ... The prostate 51 (4), 256-267, 2002 | 100 | 2002 |
| Transrectal ultrasound in the diagnosis of prostate cancer: state of the art and perspectives JP Sedelaar, PLM Vijverberg, TM De Reijke, JJ de la Rosette, PJM Kil, ... European urology 40 (3), 275-284, 2001 | 98 | 2001 |
| The application of three–dimensional contrast–enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer JP Sedelaar, RG Aarnink, GJLH van Leenders, HP Beerlage, ... European urology 37 (5), 559-568, 2000 | 97 | 2000 |
| Aldo-keto reductase family 1 member C3 (AKR1C3) is a biomarker and therapeutic target for castration-resistant prostate cancer ARAH Hamid, MJ Pfeiffer, GW Verhaegh, E Schaafsma, A Brandt, ... Molecular Medicine 18, 1449-1455, 2012 | 94 | 2012 |
| Prostate cancer staging using imaging MRW Engelbrecht, JO Barentsz, GJ Jager, M Van Der Graaf, A Heerschap, ... BJU international 86, 123-134, 2000 | 82 | 2000 |
| Cost-effectiveness comparison of imaging-guided prostate biopsy techniques: systematic transrectal ultrasound, direct in-bore MRI, and image fusion W Venderink, TM Govers, M de Rooij, JJ Fütterer, JPM Sedelaar American Journal of Roentgenology 208 (5), 1058-1063, 2017 | 80 | 2017 |
| MR imaging–guided focal cryoablation in patients with recurrent prostate cancer JGR Bomers, D Yakar, CG Overduin, JPM Sedelaar, H Vergunst, ... Radiology 268 (2), 451-460, 2013 | 76 | 2013 |
| Lutetium-177-PSMA-617 in low-volume hormone-sensitive metastatic prostate cancer: a prospective pilot study BM Privé, SMB Peters, CHJ Muselaers, IM van Oort, MJR Janssen, ... Clinical Cancer Research 27 (13), 3595-3601, 2021 | 68 | 2021 |
| Elastic versus rigid image registration in magnetic resonance imaging–transrectal ultrasound fusion prostate biopsy: a systematic review and meta-analysis W Venderink, M de Rooij, JPM Sedelaar, HJ Huisman, JJ Fütterer European urology focus 4 (2), 219-227, 2018 | 64 | 2018 |
| Of mice and men‐warning: Intact versus castrated adult male mice as xenograft hosts are equivalent to hypogonadal versus abiraterone treated aging human males, respectively JPM Sedelaar, SS Dalrymple, JT Isaacs The Prostate 73 (12), 1316-1325, 2013 | 64 | 2013 |
| Body composition in relation to clinical outcomes in renal cell cancer: a systematic review and meta-analysis A Vrieling, E Kampman, NC Knijnenburg, PF Mulders, JPM Sedelaar, ... European urology focus 4 (3), 420-434, 2018 | 63 | 2018 |
| PSMA-targeting agents for radio-and fluorescence-guided prostate cancer surgery YHW Derks, DWPM Löwik, JPM Sedelaar, M Gotthardt, OC Boerman, ... Theranostics 9 (23), 6824, 2019 | 62 | 2019 |
